What was strong about third-quarter results and fourth-quarter guidance?

  • Third-quarter 2026 revenue was 585 million dollars, up 49% quarter over quarter and 154% year over year. This was above the company’s prior guidance of 540 million to 560 million dollars and market expectations of about 550 million dollars.
  • The company expects fourth-quarter revenue of 730 million to 750 million dollars. The midpoint of 740 million dollars represents growth of about 27% from the third quarter and is above the prior market expectation of about 659 million dollars cited in the body of the report. Growth is coming from Scorpio X’s expansion to more customers and platforms, as well as growth in Aries and Taurus products.
  • Third-quarter adjusted operating margin was 44.7%, up 5.6 percentage points quarter over quarter. Adjusted earnings per share were 1.32 dollars, above the market expectation of 1.20 dollars cited in the report. The company guided to an adjusted operating margin of about 45% in the fourth quarter, while investing in core products and new businesses, and expects operating expenses to rise to 194 million to 200 million dollars.

How is Scorpio X driving growth, and what comes next?

  • Scorpio was the company’s largest product family by revenue in the third quarter, with X-series revenue exceeding that of the P series. Revenue for the entire family, annualized at the quarter’s level, exceeded 1 billion dollars. The X series shipped to two customers in the quarter, and P-series revenue also grew quarter over quarter.
  • Management said most of the initial Scorpio X platform deployment ramp has been completed and expects the platforms to contribute meaningful revenue on an ongoing basis. The next phase of growth will come from new platforms at existing customers and from new customers; the company expects the higher-priced X series to be the main driver of Scorpio growth next year.
  • A second large cloud service provider received pre-production shipments of the X series in the third quarter. Products planned for delivery to other customers in the fourth quarter are expected to complete development and qualification in the first half of 2027, with revenue contributions beginning only in the second half.

Which products will carry growth forward beyond Scorpio?

  • Adoption of PCIe Gen 6 drove Aries revenue to a third-quarter record; Taurus 800G products began volume shipments to a leading customer. Leo 2 for memory expansion is in pre-production shipments, and the company expects its volume ramp to begin around mid-2027.
  • The company expects its co-packaged optical connectivity products to begin contributing revenue in the second half of 2027, after customer qualification. It has more than 10 projects involving custom interconnects, memory controllers, and I/O chiplets, and expects shipments to begin by the end of 2027, with a volume ramp in 2028.
  • Management estimates that a fully configured Orion rack design with about 80 accelerators could include more than 100 thousand dollars’ worth of Astera components, boards, and software. The company plans to take it to market through equipment manufacturing partners in 2027; JPMorgan expects it to make a more substantial contribution only in 2028 and beyond.

Why did JPMorgan raise its estimates but maintain its price target?

  • Driven by stronger fourth-quarter guidance and product growth momentum, JPMorgan raised its 2027 adjusted earnings-per-share estimate from 6.15 dollars to 7.35 dollars, and expects 2027 revenue of 3.45 billion dollars, up 70.3% year over year.
  • The bank maintained its Overweight rating and 465 dollar price target, which corresponds to about 63 times its 2027 earnings-per-share estimate. It considers the valuation premium to the semiconductor industry supported by growth, but its model also shows adjusted gross margin declining from a projected 73.1% in 2026 to 71.6% in 2027.
  • The growth trajectory is sensitive to product timing and spending: JPMorgan noted that delays in new-product ramps, slower customer adoption of new technologies, or higher-than-expected R&D expenses could weigh on revenue or earnings growth.

Related topics